Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

235.75 +0.70 (+0.30%)
Streaming Delayed Price Updated: 1:57 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Surprise Earnings And An Ongoing Bear Market Rally
Equities crept higher yet again today as traders took in the earnings from Tesla and other major stocks. 
Via Talk Markets
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending... 
Via Benzinga
Danaher's Covid Tailwind Is In Question; Why One Analyst Isn't Worried
Endemic Covid looks different, but could still give Danaher a leg up. 
Via Investor's Business Daily
Danaher Easily Beats Q2 Street View With Growth From Base Business; FY22 Outlook Unchanged
Via Benzinga
Danaher: Q2 Earnings Insights
  Danaher (NYSE:DHR) reported its Q2 earnings results on Thursday, July 21, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Where Danaher Stands With Analysts
Within the last quarter, Danaher (NYSE:DHR) has observed the following analyst ratings: 
Via Benzinga
Earnings Scheduled For July 21, 2022
Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion. 
Via Benzinga
Earnings Outlook For Danaher
Danaher (NYSE:DHR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that Danaher will report an... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
Upgrades 
Via Benzinga
Looking Into Danaher's Recent Short Interest
Danaher's (NYSE:DHR) short percent of float has risen 20.63% since its last report. The company recently reported that it has 4.83 million shares sold short, which is 0.76% of all... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Here's How Much $100 Invested In Danaher 10 Years Ago Would Be Worth Today
Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 9.88% on an annualized basis producing an average annual return of 20.69%. Currently, Danaher has a market capitalization of... 
Via Benzinga
7 Best Healthcare Stocks to Buy Now
The move toward treating DNA as akin to a programming language is just getting started, but you can start profiting on healthcare stocks now. 
Via InvestorPlace
How Is The Market Feeling About Danaher?
Danaher's (NYSE:DHR) short percent of float has fallen 7.35% since its last report. The company recently reported that it has 3.99 million shares sold short, which is 0.63% of all... 
Via Benzinga
Here's How Much $100 Invested In Danaher 20 Years Ago Would Be Worth Today
Danaher (NYSE:DHR) has outperformed the market over the past 20 years by 7.67% on an annualized basis producing an average annual return of 14.78%. Currently, Danaher has a market capitalization of... 
Via Benzinga
The 7 Safest Blue-Chip Stocks You Can Buy Now
The safest blue-chip stocks have strong catalysts bolstering their upside. As inflation soars, investing in these stocks makes more sense. 
Via InvestorPlace
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 9.25% on an annualized basis producing an average annual return of 20.62%. Currently, Danaher has a market capitalization of... 
Via Benzinga
7 Blue-Chip Stocks to Buy for June 2022
Blue-chip stocks are a smart choice during times when economic uncertainty is expected. So, here are seven blue-chip stocks to buy right now. 
Via InvestorPlace
SCIEX Launches the New Cornerstone of Software Ecosystem - SCIEX OS 3.0
From SCIEX
Via Business Wire
SCIEX Launches the Next Generation of Data Independent Acquisition With Zeno SWATH DIA at ASMS 2022
From SCIEX
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Billionaire Dan Loeb Is Betting Big on These 3 Stocks
Dan Loeb is a veteran hedge fund manager and the CEO of Third Point. Let's take a look at his top three positions as of Q1. 
Via InvestorPlace
Jim Cramer Likes This Stock Over Olaplex
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Danaher Corporation (NYSE: DHR) over InMode Ltd. (NASDAQ: INMD). 
Via Benzinga
Danaher's Defensive Portfolio Is Ideal Amid Macro Fears: RBC Analyst
Danaher Corporation’s (NYSE: DHR) portfolio, with 75% recurring revenues and more than a 90% mix in life sciences and diagnostics, appears “incrementally more attractive” amid the currently harsh macro... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022
Upgrades 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Keybanc cut Ambarella, Inc. (NASDAQ: AMBA) price target from $160 to $120. Ambarella shares fell 5% to $81.00 in pre-market trading. 
Via Benzinga
Quant Ratings Updated on 75 Stocks
I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy. 
Via InvestorPlace
Peering Into Danaher's Recent Short Interest
Danaher's (NYSE:DHR) short percent of float has fallen 5.0% since its last report. The company recently reported that it has 4.92 million shares sold short, which is 0.76% of all... 
Via Benzinga
Sell-Side Activity Continues as we Plan for the Inflation Data in Tomorrow's CPI
Stocks continued sliding lower in another series of volatile sessions after last week's Fed Announcement and Friday Jobs Report. 
Via Talk Markets
RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics
From SCIEX
Via Business Wire
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.